🇺🇸 FDA
Patent

US 12390483

Compounds and methods for treating neurological and cardiovascular conditions

granted A61KA61K31/52A61K31/7076

Quick answer

US patent 12390483 (Compounds and methods for treating neurological and cardiovascular conditions) held by The Board of Regents of the University of Texas System expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/52, A61K31/7076, A61P, A61P25/00